pharma · Dyslipidemia at High to Very High Cardiovascular Risk · Suspected or confirmed Gram negative infections
Menarini Asia-Pacific
A.Menarini Australia Pty Limited
Menarini Asia-Pacific patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Singapore, SG
- Employees
- 720
- Programs
- 2
- Drugs
- 15
- Patents
- 0
Menarini Asia-Pacific patents
0 pharmaceutical patents indexed for Menarini Asia-Pacific. 0 expire within 24 months.
Menarini Asia-Pacific has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Menarini Asia-Pacific have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Menarini Asia-Pacific patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.